Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking

Yuanyuan Jin; Shuai Fan; Guangxin Lv; Haoyi Meng; Zhengyang Sun; Wei Jiang; Steven G. Van Lanen; Zhaoyong Yang

doi:10.1515/chem-2017-0039

Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking

Yuanyuan Jin, Shuai Fan, Guangxin Lv, Haoyi Meng, Zhengyang Sun, Wei Jiang, Steven G. Van Lanen, Zhaoyong Yang

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Capuramycin and a few semisynthetic derivatives have shown potential as anti-tuberculosis antibiotics.To understand their mechanism of action and structureactivity relationships a 3D-QSAR and molecular docking studies were performed. A set of 52 capuramycin derivatives for the training set and 13 for the validation set was used. A highly predictive MFA model was obtained with crossvalidated q² of 0.398, and non-cross validated partial least-squares (PLS) analysis showed a conventional r² of 0.976 and r²_pred of 0.839. The model has an excellent predictive ability. Combining the 3D-QSAR and molecular docking studies, a number of new capuramycin analogs with predicted improved activities were designed. Biological activity tests of one analog showed useful antibiotic activity against Mycobacterium smegmatis MC2 155 and Mycobacterium tuberculosis H37Rv. Computer-aided molecular docking and 3D-QSAR can improve the design of new capuramycin antimycobacterial antibiotics.

Original language	English
Pages (from-to)	299-307
Number of pages	9
Journal	Open Chemistry
Volume	15
Issue number	1
DOIs	https://doi.org/10.1515/chem-2017-0039
State	Published - 2017

Bibliographical note

Funding Information:
Acknowledgement: This work was supported by the National Natural Science Foundation of China (Grants No. 81321004 and 81761128016); CAMS Innovation Fund for Medical Sciences (2016-12M-3-012 and 2016-12M-3-022); Beijing Natural Science Foundation (7164279); and Central Public-interest Scientific Institution Basal Research Fund (IMBF201509).

Publisher Copyright:
© 2017 Yuanyuan Jin et al.

Keywords

3D-QSAR
Capuramycin analogue
antimycobacterial
drug design
molecular docking

ASJC Scopus subject areas

Chemistry (all)
Materials Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1515/chem-2017-0039

Cite this

@article{a1a948d21a7848d89bda23176f1ed607,

title = "Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking",

abstract = "Capuramycin and a few semisynthetic derivatives have shown potential as anti-tuberculosis antibiotics.To understand their mechanism of action and structureactivity relationships a 3D-QSAR and molecular docking studies were performed. A set of 52 capuramycin derivatives for the training set and 13 for the validation set was used. A highly predictive MFA model was obtained with crossvalidated q2 of 0.398, and non-cross validated partial least-squares (PLS) analysis showed a conventional r2 of 0.976 and r2pred of 0.839. The model has an excellent predictive ability. Combining the 3D-QSAR and molecular docking studies, a number of new capuramycin analogs with predicted improved activities were designed. Biological activity tests of one analog showed useful antibiotic activity against Mycobacterium smegmatis MC2 155 and Mycobacterium tuberculosis H37Rv. Computer-aided molecular docking and 3D-QSAR can improve the design of new capuramycin antimycobacterial antibiotics.",

keywords = "3D-QSAR, Capuramycin analogue, antimycobacterial, drug design, molecular docking",

author = "Yuanyuan Jin and Shuai Fan and Guangxin Lv and Haoyi Meng and Zhengyang Sun and Wei Jiang and {Van Lanen}, {Steven G.} and Zhaoyong Yang",

note = "Funding Information: Acknowledgement: This work was supported by the National Natural Science Foundation of China (Grants No. 81321004 and 81761128016); CAMS Innovation Fund for Medical Sciences (2016-12M-3-012 and 2016-12M-3-022); Beijing Natural Science Foundation (7164279); and Central Public-interest Scientific Institution Basal Research Fund (IMBF201509). Publisher Copyright: {\textcopyright} 2017 Yuanyuan Jin et al.",

year = "2017",

doi = "10.1515/chem-2017-0039",

language = "English",

volume = "15",

pages = "299--307",

number = "1",

}

TY - JOUR

T1 - Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking

AU - Jin, Yuanyuan

AU - Fan, Shuai

AU - Lv, Guangxin

AU - Meng, Haoyi

AU - Sun, Zhengyang

AU - Jiang, Wei

AU - Van Lanen, Steven G.

AU - Yang, Zhaoyong

N1 - Funding Information: Acknowledgement: This work was supported by the National Natural Science Foundation of China (Grants No. 81321004 and 81761128016); CAMS Innovation Fund for Medical Sciences (2016-12M-3-012 and 2016-12M-3-022); Beijing Natural Science Foundation (7164279); and Central Public-interest Scientific Institution Basal Research Fund (IMBF201509). Publisher Copyright: © 2017 Yuanyuan Jin et al.

PY - 2017

Y1 - 2017

N2 - Capuramycin and a few semisynthetic derivatives have shown potential as anti-tuberculosis antibiotics.To understand their mechanism of action and structureactivity relationships a 3D-QSAR and molecular docking studies were performed. A set of 52 capuramycin derivatives for the training set and 13 for the validation set was used. A highly predictive MFA model was obtained with crossvalidated q2 of 0.398, and non-cross validated partial least-squares (PLS) analysis showed a conventional r2 of 0.976 and r2pred of 0.839. The model has an excellent predictive ability. Combining the 3D-QSAR and molecular docking studies, a number of new capuramycin analogs with predicted improved activities were designed. Biological activity tests of one analog showed useful antibiotic activity against Mycobacterium smegmatis MC2 155 and Mycobacterium tuberculosis H37Rv. Computer-aided molecular docking and 3D-QSAR can improve the design of new capuramycin antimycobacterial antibiotics.

AB - Capuramycin and a few semisynthetic derivatives have shown potential as anti-tuberculosis antibiotics.To understand their mechanism of action and structureactivity relationships a 3D-QSAR and molecular docking studies were performed. A set of 52 capuramycin derivatives for the training set and 13 for the validation set was used. A highly predictive MFA model was obtained with crossvalidated q2 of 0.398, and non-cross validated partial least-squares (PLS) analysis showed a conventional r2 of 0.976 and r2pred of 0.839. The model has an excellent predictive ability. Combining the 3D-QSAR and molecular docking studies, a number of new capuramycin analogs with predicted improved activities were designed. Biological activity tests of one analog showed useful antibiotic activity against Mycobacterium smegmatis MC2 155 and Mycobacterium tuberculosis H37Rv. Computer-aided molecular docking and 3D-QSAR can improve the design of new capuramycin antimycobacterial antibiotics.

KW - 3D-QSAR

KW - Capuramycin analogue

KW - antimycobacterial

KW - drug design

KW - molecular docking

UR - http://www.scopus.com/inward/record.url?scp=85040254297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040254297&partnerID=8YFLogxK

U2 - 10.1515/chem-2017-0039

DO - 10.1515/chem-2017-0039

M3 - Article

AN - SCOPUS:85040254297

VL - 15

SP - 299

EP - 307

IS - 1

ER -

Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this